| SHPH Stock | | | USD 0.85 0.02 2.30% |
The current 90-days correlation between Shuttle Pharmaceuticals and Tff Pharmaceuticals is 0.11 (i.e., Average diversification). The correlation of Shuttle Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Shuttle Pharmaceuticals Correlation With Market
Good diversification
The correlation between Shuttle Pharmaceuticals and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Shuttle Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Shuttle Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more detail on how to invest in Shuttle Stock please use our
How to Invest in Shuttle Pharmaceuticals guide.
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations | ELYM | | TFFP | | INBX | | TFFP | | INBX | | ELYM | | ELVN | | INBX | | ELVN | | TFFP |
| | High negative correlations |
Risk-Adjusted IndicatorsThere is a big difference between Shuttle Stock performing well and Shuttle Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Shuttle Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.